Medical research

Stanford developing single-dose nanoparticle vaccine for COVID-19

Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, ...

Diseases, Conditions, Syndromes

What should a successful SARS-CoV-2 vaccine do?

A lot has been written recently about the merits of different potential vaccines for SARS-CoV-2. "Merit" is generally assumed to mean that the vaccine will make us immune. But what, exactly, is immunity, and how would we ...

Diseases, Conditions, Syndromes

New vaccine blocks COVID-19 and variants, plus other coronaviruses

A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections—including SARS-CoV-2 as well as the original ...

page 1 from 342